Clinical Characteristics and Outcomes in Patients with Takayasu Arteritis Coexisting with Myocardial Ischemia and Neurological Symptoms: A Multicenter, Long-term, Follow-up Study

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Aug 22

PMID 35990973

Authors

Junting Huo

Bin Wang

Lijun Yu

Dewei Gao

Rui Cheng

Jiawei Wang

Xianliang Zhou

Tao Tian

Linggen Gao

Affiliations

Soon will be listed here.

Abstract

Background: The incidence of coexisting myocardial ischemia and neurological symptoms in Takayasu arteritis (TA) is currently unknown. There is no standardized treatment algorithm in complex cases involving the coronary and intracranial arteries.

Objective: This study aimed to describe the clinical characteristics and outcomes in patients with TA coexisting with myocardial ischemia and neurological symptoms.

Methods: We retrospectively collected and assessed 1,580 patients with TA, and enrolled patients with myocardial ischemia and neurological symptoms from January 2002 to December 2021 in several hospitals. The incidence, clinical features, management strategy, and prognosis of these patients were evaluated.

Results: Ninety-four (5.9%, 94/1,580) patients with TA coexisting with myocardial ischemia and neurological symptoms were included in the present study. Imaging results showed that the subclavian arteries were the most frequently affected arteries and 37 patients had intracranial vascular abnormalities, comprising the basilar artery (6.1%, 17/279), middle cerebral artery (2.5%, 7/279), anterior cerebral artery (2.9%, 8/279), and posterior cerebral artery (1.9%, 5/279). Among patients with neurological symptoms, 25 patients underwent percutaneous transluminal angioplasty and 20 patients underwent stent implantation. The most common site of stenosis was the ostial and proximal segments of the coronary artery, with 142 lesions among 188 (75.5%) lesions. Thirty-eight patients adopted interventional therapy, 21 patients underwent surgical treatment, and the remaining 35 patients received conservative treatment. There were 20 (21.27%, 20/94) late deaths during a mean follow-up of 57.79 months. The mortality rate in the conservative treatment group was significantly higher than that in the interventional therapy and surgical treatment groups.

Conclusion: Patients with TA involving both the coronary and intracranial vessels are not rare. Stenosis and occlusion lesions most frequently involve the ostia and proximal segment of the arteries. Severe vascular lesions should be revascularized as soon as possible. These patients should be supplemented with glucocorticoids, antiplatelet, nitrates, and statins.

Citing Articles

Coronary artery lesions in Takayasu arteritis.

Dzhus M, Mostbauer H Reumatologia. 2024; 61(6):460-472.

PMID: 38322104 PMC: 10839913. DOI: 10.5114/reum/176483.

Clinical and vascular lesion characteristics of the patients with takayasu arteritis manifested firstly as acute myocardial infarction at onset.

Liu R, Xu F, Zhou Y, Shi D, Liu T Heliyon. 2023; 9(2):e13099.

PMID: 36816237 PMC: 9929309. DOI: 10.1016/j.heliyon.2023.e13099.

References

Williams M, Moss A, Dweck M, Hunter A, Pawade T, Adamson P . Standardized reporting systems for computed tomography coronary angiography and calcium scoring: A real-world validation of CAD-RADS and CAC-DRS in patients with stable chest pain. J Cardiovasc Comput Tomogr. 2019; 14(1):3-11. DOI: 10.1016/j.jcct.2019.07.010. View

Rav-Acha M, Plot L, Peled N, Amital H . Coronary involvement in Takayasu's arteritis. Autoimmun Rev. 2007; 6(8):566-71. DOI: 10.1016/j.autrev.2007.04.001. View

Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y . Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation. 2008; 118(25):2738-47. DOI: 10.1161/CIRCULATIONAHA.107.759589. View

Byrne R, Joner M, Kastrati A . Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. Eur Heart J. 2015; 36(47):3320-31. PMC: 4677274. DOI: 10.1093/eurheartj/ehv511. View

Sharma S, Saxena A, Talwar K, Kaul U, Mehta S, Rajani M . Renal artery stenosis caused by nonspecific arteritis (Takayasu disease): results of treatment with percutaneous transluminal angioplasty. AJR Am J Roentgenol. 1992; 158(2):417-22. DOI: 10.2214/ajr.158.2.1346073. View

Wilson L, Chandran A, Fudge J, Moguillansky D, Thatayatikom A, Philip J . Takayasu's arteritis presenting as acute myocardial infarction: case series and review of literature. Cardiol Young. 2021; 31(11):1866-1869. DOI: 10.1017/S1047951121001700. View

Gori T . Vascular Wall Reactions to Coronary Stents-Clinical Implications for Stent Failure. Life (Basel). 2021; 11(1). PMC: 7829777. DOI: 10.3390/life11010063. View

Iga K, Gohma I, Hori K . Regression of the left main trunk lesion by steroid administration in Takayasu's aortitis. Chest. 1991; 99(2):508-10. DOI: 10.1378/chest.99.2.508. View

Davari P, Sutton P, Jones K . Stroke as the initial presentation of Takayasu's arteritis: A case report. Radiol Case Rep. 2020; 15(5):556-559. PMC: 7082213. DOI: 10.1016/j.radcr.2019.12.019. View

10.

Yang L, Zhang H, Jiang X, Song L, Qin F, Zou Y . Clinical Features and Outcomes of Takayasu Arteritis with Neurological Symptoms in China: A Retrospective Study. J Rheumatol. 2015; 42(10):1846-52. DOI: 10.3899/jrheum.150097. View

11.

Ishikawa K . Effects of prednisolone therapy on arterial angiographic features in Takayasu's disease. Am J Cardiol. 1991; 68(4):410-3. DOI: 10.1016/0002-9149(91)90845-c. View

12.

Bond K, Nasr D, Lehman V, Lanzino G, Cloft H, Brinjikji W . Intracranial and Extracranial Neurovascular Manifestations of Takayasu Arteritis. AJNR Am J Neuroradiol. 2017; 38(4):766-772. PMC: 7960250. DOI: 10.3174/ajnr.A5095. View

13.

Mangiardi M, Bravi M, Pezzella F, Ricci L, Anticoli S . Unsuccessful Endovascular Treatment in a Patient With Stroke Onset of Takayasu Arteritis and Positive Clinical Outcome. Cureus. 2021; 12(12):e11980. PMC: 7788043. DOI: 10.7759/cureus.11980. View

14.

Johnson A, Emery D, Clifford A . Intracranial Involvement in Takayasu's Arteritis. Diagnostics (Basel). 2021; 11(11). PMC: 8624213. DOI: 10.3390/diagnostics11111997. View

15.

Wang H, Liu Z, Shen Z, Fang L, Zhang S . Impact of coronary involvement on long-term outcomes in patients with Takayasu's arteritis. Clin Exp Rheumatol. 2020; 38(6):1118-1126. View

16.

Fanelli C, ARONOFF R . Restenosis following coronary angioplasty. Am Heart J. 1990; 119(2 Pt 1):357-68. DOI: 10.1016/s0002-8703(05)80028-6. View

17.

Wen D, Du X, Ma C . Takayasu arteritis: diagnosis, treatment and prognosis. Int Rev Immunol. 2012; 31(6):462-73. DOI: 10.3109/08830185.2012.740105. View

18.

Li-xin Z, Jun N, Shan G, Bin P, Li-ying C . Neurological manifestations of Takayasu arteritis. Chin Med Sci J. 2012; 26(4):227-30. DOI: 10.1016/s1001-9294(12)60005-4. View

19.

Ullrich H, Olschewski M, Munzel T, Gori T . Coronary In-Stent Restenosis: Predictors and Treatment. Dtsch Arztebl Int. 2021; 118(38):637-644. PMC: 8715314. DOI: 10.3238/arztebl.m2021.0254. View

20.

Hwang J, Kim S, Bang O, Chung C, Lee K, Kim D . Ischemic stroke in Takayasu's arteritis: lesion patterns and possible mechanisms. J Clin Neurol. 2012; 8(2):109-15. PMC: 3391615. DOI: 10.3988/jcn.2012.8.2.109. View